MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics AG • MoonLake Immunotherapeutics Ltd • MNLK Immunotherapeutics, Unipessoal Lda, a private limited company incorporated ...

MLTX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$64.00

Low target

$61.00

High target

$67.00

Latest filings (excl ownership)

View all

8-K

Submission of Matters to a Vote of Security Holders

12 May 25

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update

12 May 25

8-K

Regulation FD Disclosure

29 Apr 25

ARS

2024 FY

Annual report to shareholders

22 Apr 25

DEFA14A

Additional proxy soliciting materials

22 Apr 25

Entry into a Material Definitive Agreement

26 Feb 25

MoonLake Immunotherapeutics Reports Full Year 2024 Financial Results and Provides a Business Update

26 Feb 25

Latest ownership filings

View all

PRICE T ROWE ASSOCIATES INC /MD/

14 May 25

da Silva Jorge Santos

Financial summary

Financial statements Chart MLTX financial data

Quarter (USD)	Mar 25	Dec 24	Sep 24	Jun 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	271.57 mm	271.57 mm	271.57 mm	271.57 mm	271.57 mm	271.57 mm
Cash burn (monthly)	(no burn)	15.57 mm	15.83 mm	14.23 mm	12.71 mm	11.65 mm
Cash used (since last report)	n/a	38.15 mm	38.78 mm	34.86 mm	31.15 mm	28.54 mm
Cash remaining	n/a	233.41 mm	232.79 mm	236.71 mm	240.42 mm	243.03 mm
Runway (months of cash)	n/a	15.0	14.7	16.6	18.9	20.9

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

MLTX institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	116	112	+3.6%
Opened positions	19	19	–
Closed positions	15	20	-25.0%
Increased positions	47	51	-7.8%
Reduced positions	32	23	+39.1%

13F shares	Current	Prev Q	Change
Total value	3.21 tn	2.95 tn	+8.9%
Total shares	82.97 mm	83.86 mm	-1.1%
Total puts	92.40 k	33.50 k	+175.8%
Total calls	121.00 k	49.70 k	+143.5%
Total put/call ratio	0.8	0.7	+13.3%

Largest owners	Shares	Value	Change
Biotechnology Value Fund L P	19.75 mm	$985.00 mm	-9.2%
BVF	19.75 mm	$1.07 tn	-9.2%
Cormorant Asset Management	8.49 mm	$459.96 bn	0.0%
FMR	6.34 mm	$343.39 bn	+28.1%
T. Rowe Price	3.34 mm	$181.06 mm	+12.2%
Avoro Capital Advisors	2.77 mm	$150.00 bn	0.0%
Citadel Advisors	2.19 mm	$118.42 bn	-5.9%
Paradigm Biocapital Advisors	1.77 mm	$95.97 bn	+90.3%
GS The Goldman Sachs Group, Inc.	1.67 mm	$90.68 bn	+12.0%
Holocene Advisors	1.59 mm	$85.84 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
Biotechnology Value Fund L P	19.75 mm	-2.00 mm	-9.2%
BVF	19.75 mm	-2.00 mm	-9.2%
FMR	6.34 mm	+1.39 mm	+28.1%
Paradigm Biocapital Advisors	1.77 mm	+840.73 k	+90.3%
Polar Capital	1.10 mm	+600.00 k	+120.0%
T. Rowe Price	3.34 mm	+363.39 k	+12.2%
Adage Capital Partners GP, L.L.C.	155.00 k	-350.00 k	-69.3%
EcoR1 Capital	332.52 k	+332.52 k	NEW
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne	85.00	-228.94 k	-100.0%
Walleye Capital	208.90 k	+208.90 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MLTX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Jun 25	Andrew John Phillips	Option to Buy Class A ordinary shares, par value $0.0001 per share	Grant	Acquire A	No	No	48.83	6,682	326.28 k	6,682
5 Jun 25	Moukheibir Catherine	Option to Buy Class A ordinary shares, par value $0.0001 per share	Grant	Acquire A	No	No	48.83	6,682	326.28 k	6,682
5 Jun 25	Ramnik Xavier	Option to Buy Class A ordinary shares, par value $0.0001 per share	Grant	Acquire A	No	No	48.83	6,682	326.28 k	6,682
5 Jun 25	Spike Loy	Option to Buy Class A ordinary shares, par value $0.0001 per share	Grant	Acquire A	No	No	48.83	6,682	326.28 k	6,682
5 Jun 25	Simon Sturge	Option to Buy Class A ordinary shares, par value $0.0001 per share	Grant	Acquire A	No	No	48.83	6,682	326.28 k	6,682